PMDA drug package insert
よろず杞菊地黄丸錠
PMDA OTC drug · （株）フォーリーフ製薬 · package insert May 20, 2026
Key facts
| Brand names | よろず杞菊地黄丸錠 |
|---|---|
| Companies | 製造販売元／大和合同製薬（株）,販売元／（株）フォーリーフ製薬 |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | 錠剤 |
| Package insert date | May 20, 2026 |
| PMDA document key | 800113_J2601000083 |
| PMDA company code | 800113 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: